https://www.selleckchem.com/pr....oducts/asciminib-abl
001; hypoglycemia episodes 3.0 vs. 2.3, p less then 0.001). In contrast, mean frequency of blood glucose testing per day increased from baseline to 3 months (2.5 vs. 5.2; p less then 0.001). Conclusion These data demonstrate improvements in diabetes distress and sleep quality as well as glycemic outcomes following 3 months' FSL use in young adults with T1DM.Introduction In pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia (FNAIT), prenatal intervention in subsequent pregnancies may be required to p
Like
Comment
Share
